Calidi Biotherapeutics(US:CLDI) Globenewswireยท2025-07-08 12:30Company Overview - Calidi Biotherapeutics Inc. is a clinical-stage immuno-oncology company focused on developing innovative cancer treatments through the precise delivery of genetic medicines to both primary tumors and metastatic sites [3][4] - The company utilizes proprietary stem cell-based platforms that can carry oncolytic viruses, aiming to enhance the efficacy and safety of cancer therapies [4] Industry Context - An estimated 20 million people are diagnosed with cancer annually, with nearly 10 million deaths each year worldwide, and these figures are projected to rise significantly [2] - The American Cancer Society anticipates that by 2050, 35 million people will be diagnosed with cancer each year, highlighting the urgent need for new and effective cancer drugs [2] Technology and Innovation - Calidi's platform employs engineered viruses to target cancer sites in the body, delivering potent genetic medicines that could potentially revolutionize cancer treatment [3] - The dual approach of using allogeneic stem cells and oncolytic viruses aims to treat or prevent metastatic disease, addressing significant unmet needs in oncology [4]